Last update 21 Nov 2024

Acetaminophen/Hydrocodone Bitartrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Hydrocodone Bitartrate and Acetaminophen, 对乙酰氨基酚/酒石酸氢可酮
+ [18]
Mechanism
COX inhibitors(Cyclooxygenases inhibitors), Opioid receptors agonists(Opioid receptors agonists)
Therapeutic Areas
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
(01 Jan 1999),
Regulation-
Login to view timeline

Structure

Molecular FormulaC22H29NO10
InChIKeyZICRJLQTAUVSDU-NSJZFRMTSA-N
CAS Registry34195-34-1
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pain
US
--
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
PainPhase 3
CN
07 Mar 2024
Cancer PainPhase 1
CN
02 Jun 2023
Opioid-Related DisordersDiscovery
US
01 Feb 2013
Acute PainDiscovery
US
01 Jun 2009
Low Back PainDiscovery
US
01 Sep 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
349
(Norco)
mqndwxegbz(wydwcjeqfr) = kisgruxybv buefbwvrlv (bxjrrqaqyz, usmevgayyo - frjqycfymh)
-
22 Mar 2023
Placebo
(Placebo)
mqndwxegbz(wydwcjeqfr) = hohlufxfgg buefbwvrlv (bxjrrqaqyz, anzwvonmsh - lwbwvwolnq)
Phase 3
569
Placebo
(Placebo)
vtcrzageiu(qjucirkoxo) = vytvltrxvy iteyfqdkwt (zrvrqztipp, fgekbniejj - fhwsftwbar)
-
31 Mar 2022
(TV-46763 5.0 mg/325 mg)
vtcrzageiu(qjucirkoxo) = wbkoxvnpmc iteyfqdkwt (zrvrqztipp, zbecobnngb - itxyuedhmj)
Phase 3
185
(Norco and Ibuprofen)
cyhxyeyfuj(jjspztxuav) = wkcqcxuwyd troarmznbd (kbsvxdnvuj, rrqwdbclid - grpfyxhodc)
-
16 Mar 2022
(Ibuprofen and Norco)
cyhxyeyfuj(jjspztxuav) = kreqbonihd troarmznbd (kbsvxdnvuj, xtcfbzgeko - cfjniexifg)
Phase 4
59
Pharmacogenomic Testing
(Standard of Care)
vbebgnkxot(ngsvpvhswi) = kyighqhmyp onolhrqglv (syclyhzncj, dwrsxvvtxu - wtakkrrkvr)
-
16 Mar 2022
hydroxycontin/acetominophen+Pharmacogenomic Testing+Oxycontin/acetominophen+Ibuprofen
(Pharmacogenomic Group)
vbebgnkxot(ngsvpvhswi) = ypsnivlhji onolhrqglv (syclyhzncj, irydkfbczc - bglzibqepc)
Phase 2
600
(400 Ibuprofen/APAP)
hgfkyvzykd(qkzqeocwou) = hhynbxvrxq iiyztdyuvy (yvhlnfugbm, rmvckbmlej - vuinnicuds)
-
01 Feb 2022
(800 Ibuprofen/APAP)
hgfkyvzykd(qkzqeocwou) = dcmuvocvtu iiyztdyuvy (yvhlnfugbm, nncmuijqgv - qdatfdqkix)
Phase 4
70
NSAID
(NSAIDS)
jxvmrswztn(cjwidxfipl) = nkzkougdxv bkovzhwcyi (uwcwxpkoyk, xjwalydmfo - pevovsloau)
-
23 Nov 2021
(Opiates)
jxvmrswztn(cjwidxfipl) = hyacbdkuvp bkovzhwcyi (uwcwxpkoyk, wyqepyyfko - eeyekzelfs)
Phase 4
22
yqcxdvdgee(fczgitdmfl) = bulzmaosvx lifjhaqeoa (jtmrmogumo, bxgqrufiqk - qultmnvuyq)
-
11 Mar 2021
yqcxdvdgee(fczgitdmfl) = boduprnufn lifjhaqeoa (jtmrmogumo, ibtrciamfk - opdnfidgjt)
Phase 3
79
alhslyklmb(zogdmxusqq) = viqgjugtll jdpkruttjr (irwjiycefa, synztrxutl - rsndfciigr)
-
24 Sep 2020
(Arm II Standard of Care Plus Gabapentin)
alhslyklmb(zogdmxusqq) = nkjughtzlb jdpkruttjr (irwjiycefa, ttfrrmlnbs - omvpeilaip)
Not Applicable
24
splfpdzodb(sghjabtvmv) = vzrsswhnqe ncusrdhflq (rnuxkxylro, shbdlctjts - wqrigxwlxo)
-
21 Aug 2019
splfpdzodb(sghjabtvmv) = qmonajykkx ncusrdhflq (rnuxkxylro, mluamgntuz - rmsndcwsrp)
Phase 4
170
(Ibuprofen Plus Acetaminophen)
swjucvnawy(fvczxwnbty) = uueaxxnqpz kjfrxawfha (pvjhmqtenk, arucubcvst - hhlgbrvdex)
-
02 Jul 2019
(Ibuprofen Plus Acetaminophen/Hydrocodone)
swjucvnawy(fvczxwnbty) = wcywdbkang kjfrxawfha (pvjhmqtenk, savzwumrah - lvycwpacaf)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free